Results 41 to 50 of about 2,048,259 (212)

A novel SF3B1 variant in a patient with MDS with ring sideroblasts [PDF]

eJHaem, 2022
Yahya A. Al‐Ghamdi, Michael J. Kluk
doaj   +2 more sources

RNA missplicing and ring sideroblasts in MDS

Blood, 2022
M. Cazzola
openaire   +3 more sources

Refractory anemia with ring sideroblasts and thrombocytosis. [PDF]

Blood Res, 2017
Pradhan S.
europepmc   +3 more sources

Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts [PDF]

Blood Neoplasia
Stefania Leone, Francesco Grimaldi, Mara Memoli, Giulia Scalia, Annamaria Vincenzi, Maria Di Perna, Giuseppe Cerciello, Antonio Vassallo, Fabrizio Pane, Alessandra Picardi, Giuseppe Terrazzano, Giuseppina Ruggiero, Flavia Carriero, Valentina Rubino   +13 more
doaj   +2 more sources

The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry

Leukemia and Lymphoma, 2023
Many patients with lower-risk myelodysplastic syndromes (LR MDS) require long-term red blood cell (RBC) transfusions to manage anemia. The consequences of RBC transfusions in LR MDS with ring sideroblasts (LR MDS-RS) are not well known.
R. Buckstein, L. Chodirker, K. Yee, M. Geddes, H. Leitch, G. Christou, V. Banerji, B. Leber, D. Khalaf, È. St-Hilaire, N. Finn, T. Nevill, M. Keating, J. Storring, A. Parmentier, Aksharh Thambipillai, D. Tang, C. Westcott, Christine Cameron, P. Spin   +19 more
semanticscholar   +1 more source

Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts

American journal of hematology/oncology, 2023
Myelodysplastic syndromes (MDS) are myeloid malignancies predomi-nating in the elderly, characterized by ineffective hematopoiesis and risk of progression to acute myeloid leukemia (AML).
L. Lanino, F. Restuccia, Alessandra Perego, M. Ubezio, B. Fattizzo, M. Riva, A. Consagra, P. Musto, D. Cilloni, E. Oliva, R. Palmieri, A. Poloni, C. Califano, I. Capodanno, F. Itri, C. Elena, C. Fozza, F. Pane, A. Pelizzari, M. Breccia, Francesco Di Bassiano, E. Crisà, D. Ferrero, V. Giai, D. Barraco, A. Vaccarino, D. Griguolo, P. Minetto, Martina Quintini, S. Paolini, G. Sanpaolo, M. Sessa, M. Bocchia, N. Di Renzo, Elisa Diral, Livia Leuzzi, A. Genua, A. Guarini, A. Molteni, Barbara Nicolino, U. Occhini, G. Rivoli, R. Bono, Anna Calvisi, A. Castelli, E. di Bona, A. Di Veroli, F. Ferrara, L. Fianchi, S. Galimberti, Daniele Grimaldi, M. Marchetti, Marianna Norata, M. Frigeni, R. Sancetta, C. Selleri, Ilaria Tanasi, P. Tosi, M. Turrini, L. Giordano, C. Finelli, P. Pasini, I. Naldi, V. Santini, M. D. della Porta   +64 more
semanticscholar   +1 more source

Extramedullary Hematopoiesis in Myelodysplastic Syndromes: A Systematic Literature Review

Hemato, 2022
Extramedullary hematopoiesis is rarely seen in patients with myelodysplastic syndromes, and its clinical characterizations are not well-defined.
Chen Wang, Yiyun Shi
doaj   +1 more source

Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late‐stage erythropoiesis

European Journal of Haematology, 2023
Patients with myelodysplastic syndromes and ring sideroblasts (MDS RS) are clinically characterized by severe anemia and transfusion need. Erythropoiesis‐stimulating agents (ESAs), which stimulate hemoglobin production and early maturation of erythroid ...
B. Fattizzo, Francesco Versino, M. Bortolotti, L. Rizzo, M. Riva, W. Barcellini   +5 more
semanticscholar   +1 more source

Ringed sideroblasts in β‐thalassemia [PDF]

Pediatric Blood & Cancer, 2016
AbstractSymptomatic β‐thalassemia is one of the globally most common inherited disorders. The initial clinical presentation is variable. Although common hematological analyses are typically sufficient to diagnose the disease, sometimes the diagnosis can be more challenging. We describe a series of patients with β‐thalassemia whose diagnosis was delayed,
Kim, Cattivelli, Dean R, Campagna, Klaus, Schmitz-Abe, Matthew M, Heeney, Hassan M, Yaish, Amy E, Caruso Brown, Susan, Kearney, Kelly, Walkovich, Kyriacos, Markianos, Mark D, Fleming, Ellis J, Neufeld   +10 more
openaire   +2 more sources

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

Research Square, 2023
Among the most common genetic alterations in the myelodysplastic syndromes (MDS) are mutations in the spliceosome gene SF3B1. Such mutations induce specific RNA missplicing events, directly promote ring sideroblast (RS) formation, generally associate ...
Inyoung Choi, Jonathan P. Ling, Jian Zhang, Eric Helmenstine, W. Walter, Riley E. Bergman, C. Philippe, James L. Manley, K. Rouault-Pierre, Bing Li, D. Wiseman, Madhu M Ouseph, E. Bernard, X. Li, T. Haferlach, Salman Fazal, Tania Jain, C. Gocke, A. Dezern, W. Dalton   +19 more
semanticscholar   +1 more source